Friday - January 09, 2026

Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Gains Momentum: 25+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Cutaneous T-cell lymphoma Pipeline Insight 2025” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Cutaneous T-cell lymphoma pipeline landscape. It covers the Cutaneous T-Cell Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading

Sobio Announces February 1, 2026 Launch of a 90-Day Virtual Recovery Program in CA, NY, NC, and FL

Sobio logo — Sobio is a virtual recovery program that combines licensed therapy with daily check-ins and structured support. Sobio announced the launch of its 90-day virtual recovery program beginning February 1, 2026 providing structured support that combines licensed therapy … Continue reading

Wrindu Provides DC Leakage and DC Withstand Voltage Testing Solutions for Enhanced Insulation Diagnostics

The Wrindu RDZG HV Hipot Tester Wrindu, a leader in electrical testing equipment, has introduced its cutting-edge DC Leakage and DC Withstand Voltage Testing Solutions to improve the performance and safety of high-voltage electrical systems. These tests, essential for evaluating … Continue reading

Creative Bioarray Introduces Advanced FISH-Based Clonality Analysis Services to Ensure Monoclonality Assurance

Recently, Creative Bioarray announced the launch of its sophisticated Fluorescent In Situ Hybridization (FISH)-based clonality analysis service. Shirley, NY – Dec 29, 2025 – As a US-leading biotechnological company, Creative Bioarray proudly develops innovative technologies for the cell biology, pharmaceutical, biotechnology, … Continue reading